We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.52B
AUM Growth
-$2.44B
Cap. Flow
-$2.44B
Cap. Flow %
-44.19%
Top 10 Hldgs %
51.97%
Holding
165
New
38
Increased
22
Reduced
40
Closed
65

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$420M
2
TRP icon
TC Energy
TRP
+$318M
3
CF icon
CF Industries
CF
+$203M
4
BABA icon
Alibaba
BABA
+$129M
5
PXD
Pioneer Natural Resource Co.
PXD
+$129M

Sector Composition

Rank Sector Weight
1 Healthcare 28.63%
2 Energy 26.23%
3 Materials 9.07%
4 Consumer Discretionary 7.49%
5 Technology 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPAY icon
51
Corpay
CPAY
$25.7B
$19.3M 0.35%
+135,600
New +$18.7M
BG icon
52
Bunge Global
BG
$20.9B
$18.8M 0.34%
+223,100
New +$18M
ISRG icon
53
Intuitive Surgical
ISRG
$127B
$18.5M 0.33%
360,000
-774,900
-68% -$38.5M
SRPT icon
54
Sarepta Therapeutics
SRPT
$1.64B
$15.3M 0.28%
725,000
-75,000
-9% -$1.69M
CFG icon
55
Citizens Financial Group
CFG
$30.1B
$14.2M 0.26%
+607,700
New +$14.1M
AEGR
56
DELISTED
Aegerion Pharmaceuticals
AEGR
$13.7M 0.25%
410,000
+160,000
+64% +$4.97M
AAL icon
57
American Airlines Group
AAL
$9.82B
$13.2M 0.24%
371,300
-555,254
-60% -$21.8M
DISH
58
DELISTED
DISH Network Corp.
DISH
$12.3M 0.22%
190,500
-172,700
-48% -$11.1M
PRTA icon
59
Prothena Corp
PRTA
$448M
$12.2M 0.22%
+550,000
New +$11.7M
JAZZ icon
60
Jazz Pharmaceuticals
JAZZ
$16.1B
$12M 0.22%
75,000
-325,000
-81% -$50M
VC icon
61
Visteon
VC
$2.85B
$11M 0.2%
113,400
-13,200
-10% -$1.32M
SBAC icon
62
SBA Communications
SBAC
$19.8B
$10.2M 0.18%
+91,700
New +$9.91M
EQT icon
63
EQT Corp
EQT
$32.9B
$9.15M 0.17%
+183,700
New +$9.73M
OEF icon
64
PUT
iShares S&P 100 ETF
OEF
$19.5B
$9.14M 0.17%
+220,000
New +$19.4M
NXPI icon
65
NXP Semiconductors
NXPI
$60.8B
$6.88M 0.12%
+100,600
New +$6.69M
SUNE
66
DELISTED
SUNEDISON, INC COM
SUNE
$6.87M 0.12%
364,050
-3,898,941
-91% -$83.6M
RLYP
67
DELISTED
RELYPSA INC COM
RLYP
$6.85M 0.12%
325,000
+125,000
+63% +$3.03M
GPRE icon
68
Green Plains
GPRE
$1.15B
$6.84M 0.12%
+183,000
New +$7.31M
UAL icon
69
United Airlines
UAL
$38.8B
$6.19M 0.11%
132,300
-149,754
-53% -$6.95M
TTPH
70
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$5.99M 0.11%
15,000
-20,000
-57% -$5.36M
AVDL
71
DELISTED
Avadel Pharmaceuticals
AVDL
$5.72M 0.1%
+400,000
New +$5.75M
CQH
72
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
$5.36M 0.1%
219,123
-1,007,556
-82% -$24.8M
ALDR
73
DELISTED
Alder Biopharmaceuticals
ALDR
$4.75M 0.09%
375,000
+100,000
+36% +$1.51M
BLUE
74
DELISTED
bluebird bio
BLUE
$4.66M 0.08%
10,036
-11,194
-53% -$5.17M
EQIX icon
75
PUT
Equinix
EQIX
$99.4B
$4.57M 0.08%
+21,500
New +$4.62M

Similar funds

PointState Capital's Q3 2014 Portfolio in Review

As of Q3 2014, PointState Capital held 165 positions worth $5.52B, down 31% from $7.96B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

PointState Capital withdrew a net $2.44B in Q3 2014, closing 65 positions and reducing 40 holdings. Its most notable exit was Paramount Global Class B, an estimated $504M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Energy and Materials.

Against the trend, PointState Capital opened a new position in AbbVie worth $437M.

  • PointState Capital's largest Q3 2014 buy was AbbVie: 7,568,600 shares worth $437M.
  • PointState Capital added most to CF Industries in Q3 2014, an estimated $203M increase.
  • PointState Capital's biggest Q3 2014 reduction was Walgreens Boots Alliance, cutting an estimated $478M.
  • PointState Capital fully exited Paramount Global Class B in Q3 2014, selling an estimated $504M.
  • PointState Capital's ten largest holdings make up 52% of its $5.52B portfolio in Q3 2014.
  • PointState Capital opened 38 new positions and closed 65 in Q3 2014.
  • PointState Capital's portfolio value fell 31% quarter-over-quarter to $5.52B.

Based on PointState Capital's 13F filing for Q3 2014, filed 14 Nov 2014.